Abstract
Monte Carlo simulations are used to determine the probability of attaining prespecified pharmacokinetic-pharmacodynamic (PK-PD) targets. Researchers in Texas recently performed such simulations to evaluate the current susceptibility breakpoints for 13 antimicrobials (21 dosing regimens) against Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii . Analysis of percent PK-PD target attainment for dosing …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
